Geode Capital Management, LLC Cyclacel Pharmaceuticals, Inc. Transaction History

Geode Capital Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$0.28 - $0.75 $6,935 - $18,576	24,769 Added 40.17%	86,425 $30,000
Q4 2022 Feb 13, 2023	SELL	$0.54 - $21.75 $86 - $3,480	-160 Reduced 0.26%	61,656 $41,000
Q2 2022 Aug 12, 2022	BUY	$6.1 - $7.15 $17,580 - $20,606	2,882 Added 4.89%	61,816 $66,000
Q3 2021 Nov 12, 2021	BUY	$8.02 - $11.0 $64,753 - $88,814	8,074 Added 15.87%	58,934 $310,000
Q2 2021 Aug 13, 2021	BUY	$7.59 - $10.48 $227,366 - $313,938	29,956 Added 143.3%	50,860 $301,000
Q1 2021 May 12, 2021	BUY	$6.86 - $9.24 $143,401 - $193,152	20,904 New	20,904 $148,000

Ticker CYCC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 12,539,200
Market Cap $7.9M
Description
Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer and other proliferative diseases. The company's development programs include fadraciclib, a cyclin dependent kinase Inhibitors (CDK) that is in Phase 1/2 clinical trial for the treatment of solid tumors, as well as in combin...

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Geode Capital Management, LLC with notifications on news.